Torben F. Ørntoft
- Cancer Research top 0.05%
- Cancer-related molecular mechanisms research 29
- MicroRNA in disease regulation 24
- Cancer Genomics and Diagnostics 23
- Molecular Biology top 0.1%
- Epigenetics and DNA Methylation 36
- Glycosylation and Glycoproteins Research 30
- RNA modifications and cancer 25
- Oncology top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 36
- Immunology top 1%
-
- Bladder and Urothelial Cancer Treatments 55
- Co-authors
- Claus L. AndersenJens Ledet JensenLars DyrskjøtMogens KruhøfferHans WolfMichael BorreThomas ThykjærKarin Birkenkamp‐Demtröder
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Torben F. Ørntoft
260 papers receiving 22.6k citations
Hit Papers
Peers
Comparison fields: 5 of 169
- Cancer Research 7.0k
- Molecular Biology 15.0k
- Oncology 3.5k
- Pathology and Forensic Medicine 1.8k
- Immunology 2.0k
Countries citing papers authored by Torben F. Ørntoft
This map shows the geographic impact of Torben F. Ørntoft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torben F. Ørntoft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torben F. Ørntoft more than expected).
Fields of papers citing papers by Torben F. Ørntoft
This network shows the impact of papers produced by Torben F. Ørntoft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torben F. Ørntoft. The network helps show where Torben F. Ørntoft may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Torben F. Ørntoft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 9 | |
| 2 | 2018 | 7 | |
| 3 | 2017 | 230 | |
| 4 | 2017 | 43 | |
| 5 | 2016 | 68 | |
| 6 | 2014 | 73 | |
| 7 | 2013 | 51 | |
| 8 | 2012 | 67 | |
| 9 | 2009 | 315 | |
| 10 | 2009 | 25 | |
| 11 | 2009 | 343 | |
| 12 | 2008 | 419 | |
| 13 | 2008 | 75 | |
| 14 | 2008 | 388 | |
| 15 | 2005 | 68 | |
| 16 | 2005 | 76 | |
| 17 | 2005 | 108 | |
| 18 | Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Setsbreakdown → | 2004 | 5912 |
| 19 | 2004 | 40 | |
| 20 | A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. | 2001 | 99 |
About Torben F. Ørntoft
Torben F. Ørntoft is a scholar working on Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 261 papers that have together received 23.0k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (55 papers), Genetic factors in colorectal cancer (36 papers), Epigenetics and DNA Methylation (36 papers), Glycosylation and Glycoproteins Research (30 papers), Cancer-related molecular mechanisms research (29 papers), RNA modifications and cancer (25 papers), MicroRNA in disease regulation (24 papers) and Cancer Genomics and Diagnostics (23 papers). The work is most often cited by research in Cancer Research (7.0k citations), Molecular Biology (15.0k citations) and Oncology (3.5k citations). Torben F. Ørntoft has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Claus L. Andersen, Jens Ledet Jensen, Lars Dyrskjøt, Mogens Kruhøffer, Hans Wolf, Michael Borre, Thomas Thykjær, Karin Birkenkamp‐Demtröder, Karina D. Sørensen and Søren Laurberg. Their work appears in journals such as Nature, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.